Posted by Reuters: Business News on April 20, 2011
NEW YORK (Reuters) – Nasdaq OMX Group , the exchange operator battling to buy out crosstown rival NYSE, showed few signs it was distracted from its core business as it logged record profit on the back of robust derivatives trading.
Posted by Reuters: Business News on
NEW YORK (Reuters) – Nasdaq OMX Group , the exchange operator battling to buy out crosstown rival NYSE, showed few signs it was distracted from its core business as it logged record profit on the back of robust derivatives trading.
Posted by Reuters: Business News on August 30, 2010
PARIS/BOSTON (Reuters) – Biotech company Genzyme Inc rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA on Monday, setting the stage for a protracted and potentially hostile takeover battle.
Posted by Reuters: Business News on
PARIS/BOSTON (Reuters) – U.S. biotech company Genzyme Inc rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA on Monday, setting the stage for a protracted and potentially hostile takeover battle.
Posted by Reuters: Business News on January 5, 2010
NEW YORK/ZURICH (Reuters) – Hopes of a takeover battle over British confectioner Cadbury receded as Nestle ruled itself out as a suitor and Kraft sweetened its hostile 10.2 billion pound ($16.4 billion) offer.
